J. Lipid Res. Please sign the JLR Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Botitsi, E.
Right arrow Articles by Siafaka-Kapadai, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Botitsi, E.
Right arrow Articles by Siafaka-Kapadai, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
The Journal of Lipid Research, Vol. 39, 1295-1304, June 1998
Copyright © 1998 by Lipid Research, Inc.


Original Article

Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells

Eleni Botitsia, Mary Mavri-Vavayannia, and Athanassia Siafaka-Kapadaia
a Department of Chemistry (Biochemistry), University of Athens, Zografou, 15771 Athens, Greece

Correspondence to: Athanassia Siafaka-Kapadai.

The metabolism of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn -glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn -glycero-3-phosphocholine) was investigated in FRTL5 cells, a normal rat thyroid cell line. FRTL5 cells incorporated [3H]PAF and deacetylated this compound to the corresponding [3H]lyso-PAF which was not accumulated or secreted but converted mainly to alkyl-acyl-phosphocholine indicating that this acylation process was particularly active in these cells. Among metabolic products of both [3H]PAF and [3H]lyso-PAF were alkylglycerol as well as its mono- and diacyl derivatives. [3H]alkylglycerol could be the intermediate compound for the production of [3H]alkyl- and [3H]alkenyl-phosphoethanolamine (plasmalogen) which were also metabolic products. FRTL5 cells were able to convert lyso-PAF to PAF especially when they were stimulated by ionophore A23187 in the presence of [3H]lyso-PAF and phenylmethylsulfonyl fluoride. The amount of PAF increased for the first 30 min and declined thereafter. PAF resting levels were found low in the same cells. Furthermore, PAF-acetylhydrolase activity was determined in cell homogenates.

The presence of metabolic products such as alkyl-phosphatidylcholine, alkyl- and alkenyl-phosphatidylethanolamine and alkyl-glycerol, as well as, its mono- and diacyl derivatives, indicates that FRTL5 cells and probably other thyroid cells, are very active in metabolizing PAF and lyso-PAF and suggests the co-operation of the corresponding metabolic pathways in these cells.—Botitsi, E., M. Mavri-Vavayanni, and A. Siafaka-Kapadai. Metabolic fate of platelet activating factor (PAF, 1-O-aklyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells. J. Lipid Res. 1998. 39: 1295–1304.

Supplementary key words: PAF metabolism, PAF biosynthesis, PAF-acetylhydrolase, plasmalogens, alkylglycerol, FRTL5 cells, thyroid


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
S. Mariggio, J. Sebastia, B. M. Filippi, C. Iurisci, C. Volonte, S. Amadio, V. De Falco, M. Santoro, and D. Corda
A novel pathway of cell growth regulation mediated by a PLA2{alpha}-derived phosphoinositide metabolite
FASEB J, December 1, 2006; 20(14): 2567 - 2569.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
Y. Denizot, T. Chianea, F. Labrousse, V. Truffinet, M. Delage, and M. Mathonnet
Platelet-activating factor and human thyroid cancer
Eur. J. Endocrinol., July 1, 2005; 153(1): 31 - 40.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.